How will stroke funding, MENA-China oncology, psilocybin&GLP-1 evolve?
From Lina's stroke recovery to Maria's GLP-1 success, this story-driven look connects funding shifts, MENA-to-China oncology moves, psilocybin prospects, and how clinicians and patients navigate trials.
Robert Maxwell
Oct 07, 2025
Stroke funding trends
Breast cancer pipeline
GLP-1 obesity adoption
psilocybin therapy trials
